Stay updated on Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial page.

Latest updates to the Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial page
- Check6 days agoChange DetectedRevision 3.5.2 has been added and Revision 3.5.0 has been removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedRevision updated to v3.5.0; previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor platform update with no changes to the study information.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision 3.4.2 was added, and the government-funding notice (and the previous Revision 3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check77 days agoChange DetectedAdded a site-wide notice about a lapse in government funding, indicating that information on the site may not be up to date and pointing readers to operating status sources. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check84 days agoChange DetectedAdded a 'Show glossary' option on the page. Updated footer/metadata labels to 'Last Update Submitted that Met QC Criteria' (capitalization), added 'No FEAR Act Data', and updated the site revision to v3.4.0 (replacing v3.3.4).SummaryDifference0.2%

Stay in the know with updates to Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial page.